Keyphrases
Adverse Outcomes
47%
Associated Anomalies
28%
Blastocyst
32%
Bloody Amniotic Fluid
28%
BNT162b2 Vaccine
56%
Cesarean Delivery
38%
Clinical Data
28%
Complication Outcome
35%
COVID-19
77%
COVID-19 Pandemic
28%
Cow's Milk Formula
56%
Early Prediction
28%
Enhanced Expression
56%
Extravillous Trophoblast
33%
Fetus
100%
Food Allergy
31%
Galectin-3 (Gal-3)
84%
Gestational Diabetes
28%
Grand multipara
28%
Infant Feeding Practices
28%
Inflammation
35%
IVF Pregnancy
28%
Maternal Blood
34%
Mediolateral Episiotomy
28%
Miscarriage
32%
Neonatal Outcome
51%
Neonatal Transfer
56%
Obstetric Complications
31%
Peripartum Infection
28%
Persistency
28%
Physiological Stress Response
28%
Placenta
47%
Postnatal Outcome
61%
Preeclampsia
31%
Pregnancy Loss
28%
Pregnancy Outcome
39%
Prenatal Diagnosis
32%
Psychological Stress Response
28%
Rate-based
28%
Retrospective Cohort Study
43%
Senescence
28%
Spontaneous Preterm Birth (sPTB)
32%
Telomere Homeostasis
31%
Thioredoxin
28%
Thioredoxin-interacting Protein (TXNIP)
28%
Trial of Labor
31%
Vacuum Cup
32%
Vacuum Delivery
65%
Vacuum-assisted Vaginal Delivery
37%
Ventricular Atrium
28%
Medicine and Dentistry
Adverse Outcome
46%
Amnion Fluid
56%
Atrium
28%
Blastocyst
36%
Cesarean Section
66%
Childbirth
42%
Cleft Lip Palate
28%
Cleft Palate
28%
Cohort Analysis
32%
Conception
28%
COVID-19
42%
COVID-19 Vaccine
28%
Delivery Complication
28%
Disease
37%
Disease Course
28%
Embryo Transfer
56%
Episiotomy
28%
Fetus Weight
56%
Food Allergy
31%
Galectin 3
28%
Hormone Substitution
28%
Hydrocortisone
28%
Immunoglobulin E
39%
Infant Feeding
28%
Infection
49%
Integrin
28%
Letrozole
28%
Magnetic Resonance Imaging
37%
Mental Stress
28%
Milk Allergy
28%
Nonmetal
28%
Obstetric Complication
31%
Physiological Stress
28%
Placenta
49%
Placenta Accreta
28%
Pre-Eclampsia
28%
Pregnancy
33%
Pregnancy Rate
33%
Prenatal Diagnosis
31%
Pyelectasis
28%
Randomized Controlled Trial
31%
Retrospective Cohort Study
41%
Sequela
31%
Severe Acute Respiratory Syndrome Coronavirus 2
28%
Spontaneous Abortion
36%
Thioredoxin
28%
Thioredoxin Interacting Protein
28%
Trial of Labor
30%
Uterine Rupture
28%
Vaginal Delivery
40%